NLO
From NLO perspective:
NLO is one of Europe’s leading Intellectual Property consultancies, advising multinationals, SMEs, universities, R&D and governmental organisations. For over 135 years, we have protected and strengthened our clients’ innovations, ideas and trademarks with a strong focus on their markets. We offer a broad range of IP services, supported by over 60 patent and 20 trademark attorneys across offices in The Hague, Amsterdam, Ede and Eindhoven.
In March 2025 NLO entered a strategic partnership with Ipsilon, a full-service IP firm based in Paris. Together, we form a team of over 400 professionals, delivering integrated IP expertise across all major technical fields and regions.
Our Pharma and Life Sciences teams bring together patent attorneys with backgrounds in pharmaceutical R&D, biotechnology and the pharmaceutical industry. Their expertise spans drug repurposing, second medical use patents, SPCs, EPO oppositions, and innovations in antibodies, vaccines and gene therapies. Combined with their IP experience, our experts can advise pharmaceutical and biotechnology companies on patent protection, portfolio management and strategic IP matters throughout the innovation lifecycle.
From a group level perspective:
NLO | IPSILON brings together leading intellectual property expertise across the Netherlands, France and Belgium. With a combined team of over 400 professionals, including experienced patent and trademark attorneys, we advise multinationals, SMEs, universities, R&D institutions and governmental organisations on protecting and strengthening their innovations, ideas and brands.
Building on NLO's 135-year experience and IPSILON's strong European presence, our group delivers integrated IP services across all major technical fields and markets.
Our dedicated Pharma and Life Sciences teams combine scientific backgrounds with extensive experience in pharmaceutical R&D, biotechnology and the pharmaceutical industry. Their expertise covers drug repurposing, second medical use patents, supplementary protection certificates (SPCs), EPO oppositions, and innovations in antibodies, vaccines and gene therapies. Together, we support pharmaceutical and biotechnology companies with patent protection, portfolio management and strategic IP advice throughout the innovation lifecycle.